X051329
Destruction Renal Sympathetic Nerve(s) to New Technology Group 9 with Ultrasound Ablation, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 0 Nervous System |
| Operation | 5 Destruction |
| Body Part | 1 Renal Sympathetic Nerve(s) |
| Approach | 3 Percutaneous |
| Device | 2 Ultrasound Ablation |
| Qualifier | 9 New Technology Group 9 |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
This family covers newer, technologically distinct methods of destroying targeted nervous system tissue, typically portions of brain tissue, using energy-based approaches that differ meaningfully from older destruction techniques already captured elsewhere in ICD-10-PCS. These procedures are most often used to treat conditions such as movement disorders, certain seizure foci, or other neurological conditions where a small, precisely targeted area of tissue is eradicated to relieve symptoms, without physically removing that tissue from the body.
Because these procedures rely on emerging technology, such as image-guided thermal or focused energy systems, they are tracked separately from standard destruction codes so that hospitals and payers can monitor the use, cost, and outcomes of new devices before they become standard practice. Patients typically undergo these procedures in a specialized neurology or neurosurgery setting, often guided by real-time imaging to confirm the treatment is limited to the intended target and spares surrounding healthy tissue.
Anatomy & Axis Detail
Renal Sympathetic Nerve(s)
The renal sympathetic nerves are a network of fine autonomic fibers running along the renal arteries that regulate blood pressure through vascular tone, renin release, and sodium handling in the kidney. Catheter-based destruction of these nerves, known as renal denervation, is performed for patients with treatment-resistant hypertension who have not achieved control despite multiple antihypertensive medications, using radiofrequency or ultrasound energy delivered endovascularly to ablate nerve fibers surrounding the artery wall without damaging the vessel lumen itself. Because the nerves are diffuse and not directly visualized, the procedure targets the arterial circumference at multiple points along both renal arteries, and documentation should reflect the energy modality and bilateral versus unilateral treatment, since new-technology codes here track a specific device-based ablation approach rather than a general nerve destruction.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Ultrasound Ablation
Ultrasound Ablation in New Technology denotes a procedure that destroys targeted tissue using focused ultrasound energy delivered through a device, distinct from thermal ablation via radiofrequency current. It is captured as a distinct emerging technology code. It differs from Focused Ultrasound Therapy, which is typically used for non-ablative therapeutic modulation rather than direct tissue destruction.
Qualifier: New Technology Group 9
Group 9 is the seventh-position qualifier used in the New Technology section to mark a device, substance, or technique as belonging to the 2022 annual cohort of new technology add-on codes. It has no clinical meaning of its own beyond that vintage tag, so coders rely on the specific table and body system to know what procedure it applies to. It is distinguished from Group 8 and Group 10 purely by the fiscal year the technology was approved for separate identification.
Coding & Documentation
Assigning a code from this family requires documentation identifying the specific new technology or device used to destroy the tissue, since New Technology section codes are tied to a particular approved technology rather than a general technique. The operative note should describe the target location within the nervous system, confirm that tissue was destroyed in place rather than excised, and reference the specific energy modality or system involved. A frequent error is defaulting to a standard Medical and Surgical section destruction code when the technology actually qualifies for a New Technology code, or vice versa, applying a New Technology code when the device used does not match the approved technology tied to that code.
Commonly Confused With
This family is easily confused with standard Destruction codes in the Medical and Surgical section's Central Nervous System body system, which cover the same root operation concept but use conventional, previously established techniques. It can also be confused with Excision or Resection, which involve physically removing tissue rather than eradicating it in place, and with Ablation-type procedures documented under different terminology; coders should verify whether tissue was removed from the body or destroyed without removal before assigning either root operation.